Suppr超能文献

乳腺癌中的 YB-1 蛋白(与 Ovchinnikov 教授的科学与个人会议)。

YB-1 Protein in Breast Cancer (Scientific and Personal Meetings with Professor Ovchinnikov).

机构信息

Department of Oncology and Radiation Therapy, Yevdokimov Moscow State University of Medicine and Dentistry, Moscow, 127473, Russia.

出版信息

Biochemistry (Mosc). 2022 Jan;87(Suppl 1):S86-S47. doi: 10.1134/S0006297922140073.

Abstract

In the article, the author examines the properties of Y-box-binding protein (YB-1) and expression of the YBX-1 gene in various malignant tumors and provides the data from her own prospective study in breast cancer patients. YB-1 is a member of the highly conserved family of cold shock proteins with multiple functions in the cytoplasm and cell nucleus. YB-1 is involved in embryogenesis; it ensures cell proliferation and protects cell from the action of various aggressive environmental factors. In adult organisms, YB-1 is involved in a variety of cellular functions that regulate malignant phenotype in several types of tumors. YB-1 is a molecular marker of tumor progression that can be used in clinical practice as both prognostic factor and a target for anticancer therapy. Our prospective clinical study showed that expression of YB-1 mRNA is an independent prognostic factor, as breast cancer patients expressing YB-1 have a lower disease-free survival rate, regardless of the tumor stage and biological subtype. We recommend determining the level of YB-1 mRNA expression as a prognostic test in breast cancer patients.

摘要

在这篇文章中,作者研究了 Y 盒结合蛋白(YB-1)的性质和 YBX-1 基因在各种恶性肿瘤中的表达,并提供了她在乳腺癌患者中的前瞻性研究数据。YB-1 是高度保守的冷休克蛋白家族的成员,在细胞质和细胞核中具有多种功能。YB-1 参与胚胎发生;它确保细胞增殖并保护细胞免受各种侵袭性环境因素的作用。在成年生物体中,YB-1 参与多种细胞功能,调节几种类型肿瘤的恶性表型。YB-1 是肿瘤进展的分子标志物,可在临床实践中用作预后因素和抗癌治疗的靶点。我们的前瞻性临床研究表明,YB-1 mRNA 的表达是独立的预后因素,因为表达 YB-1 的乳腺癌患者无论肿瘤分期和生物学亚型如何,无病生存率都较低。我们建议将 YB-1 mRNA 表达水平确定为乳腺癌患者的预后检测。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验